BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11766119)

  • 1. Psoriasis in infancy: therapy with calcipotriene ointment.
    Travis LB; Silverberg NB
    Cutis; 2001 Nov; 68(5):341-4. PubMed ID: 11766119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
    Tirado-Sánchez A; Ponce-Olivera RM
    Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriasis: role of calcipotriene.
    Kirsner RS; Federman D
    Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and topical therapy.
    Lebwohl M
    Cutis; 2002 Nov; 70(5 Suppl):5-8. PubMed ID: 12467332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and psoralen plus UVA radiation.
    Mascaró JM
    Cutis; 2002 Nov; 70(5 Suppl):13-5. PubMed ID: 12467334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of psoriasis with calcipotriol used as monotherapy.
    Ramsay CA
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
    Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
    J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R; Gramiccia T; Frascione P; Chimenti S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and scalp psoriasis.
    Koo J
    Cutis; 2002 Nov; 70(5 Suppl):21-4. PubMed ID: 12467336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group.
    Highton A; Quell J
    J Am Acad Dermatol; 1995 Jan; 32(1):67-72. PubMed ID: 7822519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Per-gram cost of medication is by itself a poor indicator for comparing costs of different psoriasis treatments: a retrospective cohort study of the cost of psoriasis treatment with topical corticosteroids versus topical calcipotriene.
    Feldman SR; Sahu S; Fleischer AB; Dezii CM
    J Cutan Med Surg; 2000 Jul; 4(3):121-5. PubMed ID: 11003715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment.
    Coynik D
    Cutis; 2000 Dec; 66(6 Suppl):19-24. PubMed ID: 11147087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
    Guzzo C; Lazarus G; Goffe BS; Katz HI; Lowe NJ; Pincus SH
    J Am Acad Dermatol; 1996 Mar; 34(3):429-33. PubMed ID: 8609254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.